{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:41:09Z","timestamp":1761964869626,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T00:00:00Z","timestamp":1494028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T00:00:00Z","timestamp":1494028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK10494"],"award-info":[{"award-number":["R01 DK10494"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00125-017-4295-2","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T06:16:29Z","timestamp":1494051389000},"page":"1423-1431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["In vivo measurement and biological characterisation of the diabetes-associated mutant insulin p.R46Q (GlnB22-insulin)"],"prefix":"10.1007","volume":"60","author":[{"given":"Julie","family":"St\u00f8y","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia U.","family":"Hj\u00f8rringgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme I.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,6]]},"reference":[{"key":"4295_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-800892-8.00002-6","volume-title":"Genetic diagnosis of endocrine disorders","author":"D Carmody","year":"2016","unstructured":"Carmody D, St\u00f8y J, Greeley SA, Bell GI, Philipson LH (2016) A clinical guide to monogenic diabetes. In: Weiss RE, Refetoff S (eds) Genetic diagnosis of endocrine disorders, 2nd edn. Academic Press, Cambridge, pp 21\u201378","edition":"2nd"},{"key":"4295_CR2","doi-asserted-by":"publisher","first-page":"15040","DOI":"10.1073\/pnas.0707291104","volume":"104","author":"J St\u00f8y","year":"2007","unstructured":"St\u00f8y J, Edghill EL, Flanagan SE et al (2007) Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 104:15040\u201315044","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4295_CR3","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.2337\/db07-1405","volume":"57","author":"EL Edghill","year":"2008","unstructured":"Edghill EL, Flanagan SE, Patch AM et al (2008) Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57:1034\u20131042","journal-title":"Diabetes"},{"key":"4295_CR4","first-page":"2148","volume":"118","author":"C Colombo","year":"2008","unstructured":"Colombo C, Porzio O, Liu M et al (2008) Seven mutations in the human insulin gene linked to permanent neonatal\/infancy-onset diabetes mellitus. J Clin Invest 118:2148\u20132156","journal-title":"J Clin Invest"},{"key":"4295_CR5","first-page":"897","volume-title":"The metabolic and molecular bases of inherited disease","author":"DF Steiner","year":"1995","unstructured":"Steiner DF, Tager HS, Nanjo K, Chan SJ, Rubenstein AH (1995) Familial syndromes of hyperproinsulinemia and hyperinsulinemia with mild diabetes. In: Scriver CR, Beaudet AL, Sly AS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 897\u2013904"},{"key":"4295_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2337\/db07-1467","volume":"57","author":"A Molven","year":"2008","unstructured":"Molven A, Ringdal M, Nordbo AM et al (2008) Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes 57:1131\u20131135","journal-title":"Diabetes"},{"key":"4295_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2350-11-42","volume":"11","author":"TW Boesgaard","year":"2010","unstructured":"Boesgaard TW, Pruhova S, Andersson EA et al (2010) Further evidence that mutations in INS can be a rare cause of maturity-onset diabetes of the young (MODY). BMC Med Genet 11:42","journal-title":"BMC Med Genet"},{"key":"4295_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2337\/db09-1091","volume":"59","author":"G Meur","year":"2010","unstructured":"Meur G, Simon A, Harun N et al (2010) Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention. Diabetes 59:653\u2013661","journal-title":"Diabetes"},{"key":"4295_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejmg.2015.02.004","volume":"58","author":"L Dusatkova","year":"2015","unstructured":"Dusatkova L, Dusatkova P, Vosahlo J et al (2015) Frameshift mutations in the insulin gene leading to prolonged molecule of insulin in two families with maturity-onset diabetes of the young. Eur J Med Genet 58:230\u2013234","journal-title":"Eur J Med Genet"},{"key":"4295_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2337\/db07-1358","volume":"57","author":"M Polak","year":"2008","unstructured":"Polak M, Dechaume A, Cave H et al (2008) Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes 57:1115\u20131119","journal-title":"Diabetes"},{"key":"4295_CR11","doi-asserted-by":"publisher","first-page":"E403","DOI":"10.1152\/ajpendo.00592.2009","volume":"298","author":"S Rajan","year":"2010","unstructured":"Rajan S, Eames SC, Park SY et al (2010) In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes. Am J Physiol Endocrinol Metab 298:E403\u2013E410","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4295_CR12","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.bbrc.2009.12.090","volume":"391","author":"SY Park","year":"2010","unstructured":"Park SY, Ye H, Steiner DF, Bell GI (2010) Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted. Biochem Biophys Res Commun 391:1449\u20131454","journal-title":"Biochem Biophys Res Commun"},{"key":"4295_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2337\/diabetes.52.2.409","volume":"52","author":"T Izumi","year":"2003","unstructured":"Izumi T, Yokota-Hashimoto H, Zhao S, Wang J, Halban PA, Takeuchi T (2003) Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes 52:409\u2013416","journal-title":"Diabetes"},{"key":"4295_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2337\/diab.46.5.887","volume":"46","author":"M Yoshioka","year":"1997","unstructured":"Yoshioka M, Kayo T, Ikeda T, Koizumi A (1997) A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL\/6 (Akita) mutant mice. Diabetes 46:887\u2013894","journal-title":"Diabetes"},{"key":"4295_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2014.12.001","volume":"42","author":"M Liu","year":"2014","unstructured":"Liu M, Sun J, Cui J et al (2014) INS-gene mutations: from genetics and beta cell biology to clinical disease. Mol Asp Med 42:3\u201318","journal-title":"Mol Asp Med"},{"key":"4295_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.tem.2010.07.001","volume":"21","author":"M Liu","year":"2010","unstructured":"Liu M, Hodish I, Haataja L et al (2010) Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth. Trends Endocrinol Metab: TEM 21:652\u2013659","journal-title":"Trends Endocrinol Metab: TEM"},{"key":"4295_CR17","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1210\/jc.2005-0196","volume":"90","author":"A Johansen","year":"2005","unstructured":"Johansen A, Ek J, Mortensen HB, Pedersen O, Hansen T (2005) Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. J Clin Endocrinol Metab 90:4607\u20134614","journal-title":"J Clin Endocrinol Metab"},{"key":"4295_CR18","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1021\/bi800054z","volume":"47","author":"T Glendorf","year":"2008","unstructured":"Glendorf T, Sorensen AR, Nishimura E, Pettersson I, Kjeldsen T (2008) Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding. Biochemistry 47:4743\u20134751","journal-title":"Biochemistry"},{"key":"4295_CR19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/clinchem\/39.4.578","volume":"39","author":"L Andersen","year":"1993","unstructured":"Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39:578\u2013582","journal-title":"Clin Chem"},{"key":"4295_CR20","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.2337\/db13-0949","volume":"63","author":"AS Dimas","year":"2014","unstructured":"Dimas AS, Lagou V, Barker A et al (2014) Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63:2158\u20132171","journal-title":"Diabetes"},{"key":"4295_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112883","volume":"9","author":"K Krizkova","year":"2014","unstructured":"Krizkova K, Veverka V, Maletinska L et al (2014) Structural and functional study of the GlnB22-insulin mutant responsible for maturity-onset diabetes of the young. PLoS One 9:e112883","journal-title":"PLoS One"},{"key":"4295_CR22","doi-asserted-by":"crossref","unstructured":"Menting JG, Yang Y, Chan SJ, et al. (2014) Protective hinge in insulin opens to enable its receptor engagement. Proc Natl Acad Sci USA","DOI":"10.1073\/pnas.1412897111"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4295-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4295-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4295-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T12:50:22Z","timestamp":1692795022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4295-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,6]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4295"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4295-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"type":"print","value":"0012-186X"},{"type":"electronic","value":"1432-0428"}],"subject":[],"published":{"date-parts":[[2017,5,6]]},"assertion":[{"value":"21 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data from the study are available from the corresponding author on request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The in vitro studies were supported by NIDDK grants P30 DK020595 and R01 DK10494 and by a gift from the Kovler Family Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"JO and CUH are employees of, and own stocks in, Novo Nordisk. JS, S-YP, SG and GIB declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"All authors conceived and designed the study. JS, JO, CUH and S-YP collected and analysed the data. JS and JO wrote the first draft of the manuscript. All authors revised the manuscript critically and gave final approval of the submitted version. JS is the guarantor of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}